The first Psychemedics trade was made in Q2 2013.
Since then Jim Simons bought shares fifteen more times and sold shares on 31 occasions. The investor sold all their shares in Q4 2024 and doesn't own any shares in Psychemedics anymore.
Avg closing price
Price range
Sold -271 Thousand shares
Q4 2024
Avg closing price
$2.47
Price range
$2.30
-
$3.20
Increased shares by 5.4% (+13.9 Thousand shares)
Q3 2024
Avg closing price
$2.25
Price range
$1.64
-
$2.44
Sold 1.1% shares (-2.9 Thousand shares)
Q2 2024
Avg closing price
$2.55
Price range
$2.24
-
$2.89
Sold 2.1% shares (-5.7 Thousand shares)
Q1 2024
Avg closing price
$3.17
Price range
$2.92
-
$3.79
Sold 3.0% shares (-8.1 Thousand shares)
Q4 2023
Avg closing price
$2.67
Price range
$2.06
-
$3.69
Sold 1.5% shares (-4.3 Thousand shares)
Q3 2023
Avg closing price
$4.46
Price range
$3.66
-
$5.05
Sold 1.2% shares (-3.3 Thousand shares)
Q2 2023
Avg closing price
$5.06
Price range
$4.55
-
$5.60
Sold 3.2% shares (-9.2 Thousand shares)
Q1 2023
Avg closing price
$5.54
Price range
$4.93
-
$6.47
Sold 5.1% shares (-15.7 Thousand shares)
Q4 2022
Avg closing price
$5.90
Price range
$4.90
-
$6.66
Sold 6.1% shares (-20 Thousand shares)
Q3 2022
Avg closing price
$6.43
Price range
$6.08
-
$6.84
Sold 4.5% shares (-15.3 Thousand shares)
Q2 2022
Avg closing price
$6.41
Price range
$6.10
-
$7.04
Sold 8.3% shares (-30.7 Thousand shares)
Q1 2022
Avg closing price
$7.08
Price range
$6.49
-
$7.56
Sold 0.3% shares (-1.29 Thousand shares)
Q4 2021
Avg closing price
$8.00
Price range
$6.86
-
$8.79
Sold 2.8% shares (-10.9 Thousand shares)
Q3 2021
Avg closing price
$7.32
Price range
$6.31
-
$8.40
Sold 7.1% shares (-29.3 Thousand shares)
Q2 2021
Avg closing price
$7.01
Price range
$6.25
-
$8.25
Sold 9.0% shares (-41 Thousand shares)
Q1 2021
Avg closing price
$6.63
Price range
$4.95
-
$7.70
Sold 0.0% shares (-100 shares)
Q4 2020
Avg closing price
$4.34
Price range
$3.67
-
$5.10
Sold 2.9% shares (-13.7 Thousand shares)
Q3 2020
Avg closing price
$4.87
Price range
$4.33
-
$6.05
Increased shares by 5.6% (+24.8 Thousand shares)
Q2 2020